| UniProt ID | TMX1_HUMAN | |
|---|---|---|
| UniProt AC | Q9H3N1 | |
| Protein Name | Thioredoxin-related transmembrane protein 1 | |
| Gene Name | TMX1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 280 | |
| Subcellular Localization |
Membrane Single-pass type I membrane protein . Endoplasmic reticulum membrane Single-pass type I membrane protein . Predominantly found in the endoplasmic reticulum. |
|
| Protein Description | May participate in various redox reactions through the reversible oxidation of its active center dithiol to a disulfide and catalyze dithiol-disulfide exchange reactions.. | |
| Protein Sequence | MAPSGSLAVPLAVLVLLLWGAPWTHGRRSNVRVITDENWRELLEGDWMIEFYAPWCPACQNLQPEWESFAEWGEDLEVNIAKVDVTEQPGLSGRFIITALPTIYHCKDGEFRRYQGPRTKKDFINFISDKEWKSIEPVSSWFGPGSVLMSSMSALFQLSMWIRTCHNYFIEDLGLPVWGSYTVFALATLFSGLLLGLCMIFVADCLCPSKRRRPQPYPYPSKKLLSESAQPLKKVEEEQEADEEDVSEEEAESKEGTNKDFPQNAIRQRSLGPSLATDKS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 102 | Phosphorylation | FIITALPTIYHCKDG EEEEECCEEEECCCC | 34.71 | 28152594 | |
| 104 | Phosphorylation | ITALPTIYHCKDGEF EEECCEEEECCCCCC | 12.02 | 28152594 | |
| 106 | S-palmitoylation | ALPTIYHCKDGEFRR ECCEEEECCCCCCHH | 2.11 | 29575903 | |
| 107 | Ubiquitination | LPTIYHCKDGEFRRY CCEEEECCCCCCHHC | 56.29 | 33845483 | |
| 107 | 2-Hydroxyisobutyrylation | LPTIYHCKDGEFRRY CCEEEECCCCCCHHC | 56.29 | - | |
| 120 | Ubiquitination | RYQGPRTKKDFINFI HCCCCCCHHHHHHHC | 52.18 | 23000965 | |
| 121 | Ubiquitination | YQGPRTKKDFINFIS CCCCCCHHHHHHHCC | 58.20 | 23000965 | |
| 121 | 2-Hydroxyisobutyrylation | YQGPRTKKDFINFIS CCCCCCHHHHHHHCC | 58.20 | - | |
| 130 | Ubiquitination | FINFISDKEWKSIEP HHHHCCCCCCCCCCC | 59.70 | 29967540 | |
| 130 | 2-Hydroxyisobutyrylation | FINFISDKEWKSIEP HHHHCCCCCCCCCCC | 59.70 | - | |
| 165 | S-palmitoylation | LSMWIRTCHNYFIED HHHHHHHHHHHHHHH | 1.09 | 29575903 | |
| 205 | S-palmitoylation | CMIFVADCLCPSKRR HHHHHHHHCCCCCCC | 2.80 | 22045338 | |
| 207 | S-palmitoylation | IFVADCLCPSKRRRP HHHHHHCCCCCCCCC | 4.49 | 22045338 | |
| 217 | Phosphorylation | KRRRPQPYPYPSKKL CCCCCCCCCCCCHHH | 15.34 | 28152594 | |
| 219 | Phosphorylation | RRPQPYPYPSKKLLS CCCCCCCCCCHHHHC | 17.81 | 28152594 | |
| 221 | Phosphorylation | PQPYPYPSKKLLSES CCCCCCCCHHHHCCC | 36.26 | 23401153 | |
| 222 | Ubiquitination | QPYPYPSKKLLSESA CCCCCCCHHHHCCCC | 42.83 | 23000965 | |
| 222 | 2-Hydroxyisobutyrylation | QPYPYPSKKLLSESA CCCCCCCHHHHCCCC | 42.83 | - | |
| 223 | Ubiquitination | PYPYPSKKLLSESAQ CCCCCCHHHHCCCCC | 60.02 | 23000965 | |
| 226 | Phosphorylation | YPSKKLLSESAQPLK CCCHHHHCCCCCCCH | 39.68 | 29255136 | |
| 228 | Phosphorylation | SKKLLSESAQPLKKV CHHHHCCCCCCCHHH | 28.91 | 30266825 | |
| 233 | Acetylation | SESAQPLKKVEEEQE CCCCCCCHHHHHHHH | 62.55 | 25953088 | |
| 233 | Ubiquitination | SESAQPLKKVEEEQE CCCCCCCHHHHHHHH | 62.55 | 21906983 | |
| 233 | 2-Hydroxyisobutyrylation | SESAQPLKKVEEEQE CCCCCCCHHHHHHHH | 62.55 | - | |
| 234 | Ubiquitination | ESAQPLKKVEEEQEA CCCCCCHHHHHHHHC | 63.66 | - | |
| 247 | Phosphorylation | EADEEDVSEEEAESK HCCCCCCCHHHHHHH | 52.17 | 29255136 | |
| 253 | Phosphorylation | VSEEEAESKEGTNKD CCHHHHHHHCCCCCC | 42.95 | 22167270 | |
| 257 | Phosphorylation | EAESKEGTNKDFPQN HHHHHCCCCCCCCHH | 39.94 | 23927012 | |
| 259 | Ubiquitination | ESKEGTNKDFPQNAI HHHCCCCCCCCHHHH | 61.66 | 33845483 | |
| 270 | Phosphorylation | QNAIRQRSLGPSLAT HHHHHHHCCCCCHHC | 29.37 | 29255136 | |
| 274 | Phosphorylation | RQRSLGPSLATDKS- HHHCCCCCHHCCCC- | 28.92 | 30266825 | |
| 277 | Phosphorylation | SLGPSLATDKS---- CCCCCHHCCCC---- | 49.61 | 30266825 | |
| 279 | Acetylation | GPSLATDKS------ CCCHHCCCC------ | 54.43 | 25953088 | |
| 279 | Ubiquitination | GPSLATDKS------ CCCHHCCCC------ | 54.43 | 24816145 | |
| 280 | Phosphorylation | PSLATDKS------- CCHHCCCC------- | 48.54 | 30266825 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TMX1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TMX1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TMX1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| LMAN1_HUMAN | LMAN1 | physical | 26344197 | |
| SSRA_HUMAN | SSR1 | physical | 26344197 | |
| THIO_HUMAN | TXN | physical | 26344197 | |
| VDAC1_HUMAN | VDAC1 | physical | 26344197 | |
| VDAC2_HUMAN | VDAC2 | physical | 26344197 | |
| VDAC3_HUMAN | VDAC3 | physical | 26344197 | |
| FGFR4_HUMAN | FGFR4 | physical | 28514442 | |
| PLXB2_HUMAN | PLXNB2 | physical | 28514442 | |
| EHD1_HUMAN | EHD1 | physical | 28514442 | |
| CD320_HUMAN | CD320 | physical | 28514442 | |
| GMCL1_HUMAN | GMCL1 | physical | 28514442 | |
| EPHA7_HUMAN | EPHA7 | physical | 28514442 | |
| GRM1C_HUMAN | GRAMD1C | physical | 28514442 | |
| GRM1B_HUMAN | GRAMD1B | physical | 28514442 | |
| NRP1_HUMAN | NRP1 | physical | 28514442 | |
| GRM1A_HUMAN | GRAMD1A | physical | 28514442 | |
| LRFN1_HUMAN | LRFN1 | physical | 28514442 | |
| PDXL2_HUMAN | PODXL2 | physical | 28514442 | |
| CSPG5_HUMAN | CSPG5 | physical | 28514442 | |
| SQSTM_HUMAN | SQSTM1 | physical | 28514442 | |
| T179B_HUMAN | TMEM179B | physical | 28514442 | |
| CD276_HUMAN | CD276 | physical | 28514442 | |
| UFSP2_HUMAN | UFSP2 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247; SER-270 ANDSER-280, AND MASS SPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247, AND MASSSPECTROMETRY. | |
| "Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247; SER-270 ANDSER-280, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280, AND MASSSPECTROMETRY. | |
| "Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247, AND MASSSPECTROMETRY. | |